Literature DB >> 1563315

Human gut hormone profiles in patients with short bowel syndrome.

N J Andrews1, M H Irving.   

Abstract

We have studied gut hormone profiles in a small number of patients on treatment with home parenteral nutrition following near-total enterectomy who had no evidence of inflammatory bowel disease and who were otherwise healthy. These and age- and sex-matched controls had gut hormone profiles measured after an overnight fast and a standard test meal. Circulating pancreatic glucagon concentrations and profiles were the same in both groups as were the neurotensin and VIP. Peptide YY (PYY) concentrations and profiles were markedly raised in the short bowel group. It is suggested that the normal glucagon responses reflect the integrity of the remaining duodenum and pancreas. Circulating neurotensin and VIP originate largely from outside the bowel and so the removal of the gut source does not significantly affect their profiles. Enteroglucagon and PYY are secreted from terminal ileum and colon in response to unabsorbed food residues. The elevated circulating levels and profiles are consistent with those observed by others in patients with jejunoileal bypass or major resections in whom unabsorbed nutrients reach the colon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563315     DOI: 10.1007/bf01296430

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

Review 1.  Plasma hormone concentrations in gastrointestinal disease.

Authors:  S R Bloom; J M Polak
Journal:  Clin Gastroenterol       Date:  1980-09

2.  Effect of total parenteral nutrition on gut hormone release in humans.

Authors:  G R Greenberg; S L Wolman; N D Christofides; S R Bloom; K N Jeejeebhoy
Journal:  Gastroenterology       Date:  1981-05       Impact factor: 22.682

3.  Measurement of fasting and postprandial plasma VIP in man.

Authors:  S J Mitchell; S R Bloom
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

4.  Gut hormone responses after reconstructive surgery for ulcerative colitis.

Authors:  G R Greenberg; A M Buchan; R S McLeod; P Preston; Z Cohen
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

5.  Human distribution and release of a putative new gut hormone, peptide YY.

Authors:  T E Adrian; G L Ferri; A J Bacarese-Hamilton; H S Fuessl; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

6.  Peptide YY abnormalities in gastrointestinal diseases.

Authors:  T E Adrian; A P Savage; A J Bacarese-Hamilton; K Wolfe; H S Besterman; S R Bloom
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

7.  Home parenteral nutrition in the United Kingdom and Ireland.

Authors:  M Mughal; M Irving
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

  7 in total
  13 in total

Review 1.  Enhancing bowel adaptation in short bowel syndrome.

Authors:  Palle Bekker Jeppesen; Per Brobech Mortensen
Journal:  Curr Gastroenterol Rep       Date:  2002-08

Review 2.  Novel agents in the treatment of intestinal failure: humoral factors.

Authors:  Hua Yang; Daniel H Teitelbaum
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

Review 3.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Obesity treatment: novel peripheral targets.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

5.  Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying.

Authors:  E Näslund; P Grybäck; L Backman; H Jacobsson; J J Holst; E Theodorsson; P M Hellström
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

Review 6.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

7.  Ileal absorptive adaptation to jejunal resection and extrinsic denervation: implications for living-related small bowel transplantation.

Authors:  G G Tsiotos; M L Kendrick; K Libsch; K Bierens; P Lankisch; J A Duenes; M G Sarr
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

Review 8.  Upper gastrointestinal function and glycemic control in diabetes mellitus.

Authors:  Reawika Chaikomin; Christopher K Rayner; Karen-L Jones; Michael Horowitz
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

9.  Peptide YY selectively stimulates expression of the colonocytic phenotype.

Authors:  S A Sgambati; G A Turowski; M D Basson
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

10.  Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.

Authors:  P Layer; J J Holst; D Grandt; H Goebell
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.